-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Entero Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2021 to Q1 2024.
- Entero Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $12.3K, a 68% increase year-over-year.
- Entero Therapeutics, Inc. Depreciation, Depletion and Amortization for the twelve months ending March 31, 2024 was $34K, a 17.1% increase year-over-year.
- Entero Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $29K, unchanged from 2022.
- Entero Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $29K, a 93.3% increase from 2021.
- Entero Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $15K, a 60.5% decline from 2020.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)